Related Articles
Multifactorial expression of IL‑6 with update on COVID‑19 and the therapeutic strategies of its blockade (Review)
Sarilumab administration in patients with severe COVID‑19: A report of four cases and a literature review
Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells
Jinhua Qinggan granule, a Chinese herbal medicine against COVID‑19, induces rapid changes in the neutrophil/lymphocyte ratio and plasma levels of IL‑6 and IFN‑γ: An open‑label, single‑arm pilot study
Association between the expression levels of IL‑6 and IL‑6R in the hepatocellular carcinoma microenvironment and postoperative recurrence